Journal of Cancer Research and Clinical Oncology

Article	Citations
Estimating the global burden of Epstein–Barr virus-related cancers	107
Role of lung and gut microbiota on lung cancer pathogenesis	101
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients	72
Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study	70
Gut microbiota-derived metabolites in CRC progression and causation	61
Cannabinoids in the landscape of cancer	60
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters	56
Predictive biomarkers in gastric cancer	53
Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis	49
Cancer patients’ perspective on shared decision-making and decision aids in oncology	49
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer	47
Current trends of targeted therapy for oral squamous cell carcinoma	46
3D tumor angiogenesis models: recent advances and challenges	44
Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art	42
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells	41
Targeting tumor vascularization: promising strategies for vascular normalization	39
CD36: an emerging therapeutic target for cancer and its molecular mechanisms	38
A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression	38
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients	38
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials	37
High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)	35
The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review	34
Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies	34
Large language models for oncological applications	33
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives	32

Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT	32
Cancer immune escape: the role of antigen presentation machinery	31
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing	31
Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial	31
Inflammatory markers in autoimmunity induced by checkpoint inhibitors	31
MAPK signaling pathway-targeted marine compounds in cancer therapy	30
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observati	30
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy	30
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board	29
Subtyping non-small cell lung cancer by histology-guided spatial metabolomics	28
The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma	28
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer	28
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective	28
Emerging role of exosomes and exosomal microRNA in cancer: pathophysiology and clinical potential	28
Human TERT promoter mutations as a prognostic biomarker in glioma	28
An overview and a roadmap for artificial intelligence in hematology and oncology	27
Radiotherapy resistance: identifying universal biomarkers for various human cancers	27
Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI	26
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases	26
Triple negative breast cancer: approved treatment options and their mechanisms of action	26
Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort	25
Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis	24
Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects	24
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China	24
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity	23
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing	23
Machine learning and deep learning techniques for breast cancer diagnosis and classification: a comprehensive review of medical imaging studies	23
Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study	23
Application of four nutritional risk indexes in perioperative management for esophageal cancer patients	23
Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma	23
Classification of skin cancer stages using a AHP fuzzy technique within the context of big data healthcare	22
Multiple functions of p21 in cancer radiotherapy	22
Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death	22
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California	22
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach	22
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer	22
Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer	21
Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin	21
Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors	21
Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective singl	21
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer	21
Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements	21
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance	21
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review	21
Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries	20
Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1	20
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy	20
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways	20
Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis	19
Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes	19

TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction	19
Cancer-associated inflammation: pathophysiology and clinical significance	19
Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer	19
Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer	19
3D mixed-reality visualization of medical imaging data as a supporting tool for innovative, minimally invasive surgery for gastrointestinal tumors and systemic treatment as a new path in personalized	19
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling	19
Risk of lung cancer and renin–angiotensin blockade: a concise review	19
Water therapies (hydrotherapy, balneotherapy or aqua therapy) for patients with cancer: a systematic review	19
Expression of estrogen-related receptors in ovarian cancer and impact on survival	19
Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China	18
Aurora B kinase: a potential drug target for cancer therapy	18
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers	18
Targeted therapy for osteosarcoma: a review	18
Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma	18
MDFNet: application of multimodal fusion method based on skin image and clinical data to skin cancer classification	18
Tumor patients’ fears and worries and perceived changes of specific attitudes, perceptions and behaviors due to the COVID-19 pandemic are still relevant	18
Molecular targeted treatment and drug delivery system for gastric cancer	18
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network	17
Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1	17
Metabolic changes during prostate cancer development and progression	17
Non-melanoma skin cancer diagnosis: a comparison between dermoscopic and smartphone images by unified visual and sonification deep learning algorithms	17
Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC	17
Take care or “German Angst”? Lessons from cancer care during COVID-19 pandemic in spring 2020	17
Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis	17
Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment	17
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling	17
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: a cross-sectional survey	17
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns	16
Costs and clinical benefits of enhanced recovery after surgery (ERAS) in pancreaticoduodenectomy: an updated systematic review and meta-analysis	16
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment	16
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial	16
Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents	16
BDNF and its signaling in cancer	16
Ten–eleven translocase: key regulator of the methylation landscape in cancer	16
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience	16
Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases	16
Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer	16
Genomic landscape of colorectal carcinogenesis	16
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small	16
Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany	16
Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resection	15
Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention	15
Applications of artificial intelligence multiomics in precision oncology	15
Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases	15
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)	15
The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review	15
Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer	15
Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C	15
Resilience in cancer patients and how it correlates with demographics, psychological factors, and lifestyle	15
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome	15
N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression	14
A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer	14
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard tre	14
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities	14
Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis	14
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases	14
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma	14
Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer	14
Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications	14
Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion	14
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma	14
Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study	14
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia	14
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma	14
Automatic breast cancer diagnosis based on hybrid dimensionality reduction technique and ensemble classification	14
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology g	14
SWI/SNF chromatin remodeling complex alterations in meningioma	14
Association between compliance with enhanced recovery after surgery (ERAS) protocols and postoperative outcome in patients with primary liver cancer undergoing hepatic resection	14
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study	13
Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030	13
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor	13
Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases	13
Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion	13
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers	13
Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors	13
Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers	13
Cancer patients’ experiences and preferences when receiving bad news: a qualitative study	13
Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma	13
Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma	13
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project	13

Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping	13
Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care	13
FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression	13
Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral res	13
Artificial intelligence in oncology: chances and pitfalls	12
The role of microRNA-30c in targeting interleukin 6, as an inflammatory cytokine, in the mesenchymal stem cell: a therapeutic approach in colorectal cancer	12
Neutrophil extracellular traps facilitate cancer metastasis: cellular mechanisms and therapeutic strategies	12
Deep learning combined with radiomics for the classification of enlarged cervical lymph nodes	12
Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer	12
Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer	12
Combining radiation to EGFR and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma	12
Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy	12
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study	12
Nanoparticles drug delivery for 5-aminolevulinic acid (5-ALA) in photodynamic therapy (PDT) for multiple cancer treatment: a critical review on biosynthesis, detection, and therapeutic applications	12
Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review	12
Downregulation of lncRNA TSLNC8 promotes melanoma resistance to BRAF inhibitor PLX4720 through binding with PP1α to re-activate MAPK signaling	12
Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients	12
How effective is peer-to-peer support in cancer patients and survivors? A systematic review	12
Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach	12
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis	12
Association between secondhand smoke and cancers in adults in the US population	12
Prevalence and severity of anxiety in cancer patients: results from a multi-center cohort study in Germany	12
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients	12
Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma	12
A comprehensive analysis of recent advancements in cancer detection using machine learning and deep learning models for improved diagnostics	12
Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database	11
Prediction model of 3-year survival after endoscopic submucosal dissection for early gastric cancer in elderly patients aged ≥ 85 years: EGC-2 model	11
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers	11
HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer	11
The previously common post-kidney transplant Kaposi sarcoma has become non-existent for a decade: an Egyptian experience	11
MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors	11
The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time	11
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience	11
Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer	11
Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma	11
Causal relationship between cannabis use and cancer: a genetically informed perspective	11
Using ultrasound-targeted microbubble destruction to enhance radiotherapy of glioblastoma	11
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer	11
Implication of gut microbes and its metabolites in colorectal cancer	11
Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga–PSMA uptake in LNCaP cells	11
Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan, China	11
The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors	11
Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer	11
Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies	11
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients	11
The role of Pcdh10 in neurological disease and cancer	11
Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1	11
Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis	11
Acute kidney injury in advanced lung cancer patients treated with PD-1 inhibitors: a single center observational study	11
The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection	11
Diet and gastric cancer risk: an umbrella review of systematic reviews and meta-analyses of prospective cohort studies	11
Differential expression of stem cell markers in proliferating cells in glioma	11
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study	11
Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer	11
Blood lipids and risk of colon or rectal cancer: a Mendelian randomization study	11
Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial–mesenchymal transition through the Wnt/β-catenin signaling pathway	11
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma	11
Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?	10
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals	10
Real world data on IO-based therapy for metastatic renal cell carcinoma	10
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic	10
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung	10
Diet-related interventions for cancer-associated cachexia	10
Exosome-mediated crosstalk between tumor cells and innate immune cells: implications for cancer progression and therapeutic strategies	10
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment	10
Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis	10
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis	10
Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer	10
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer	10
Adverse outcomes and health-ecological influencing factors of preoperative frailty among elderly patients with gastric cancer	10
Three-dimensional models: a novel approach for lymphoma research	10
CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer	10
Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a	10
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study	10
Liquid biopsy: early and accurate diagnosis of brain tumor	10
Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients	10
Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study	10
Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma	10
Meta-analysis of aspirin-guided therapy of colorectal cancer	10
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors	10
A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation	10
The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients	10
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs	10
Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype	10
Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer	10
TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features	10
Solitary colorectal liver metastasis: overview of treatment strategies and role of prognostic factors	9
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial	9
Immunotherapy for the treatment of advanced nasopharyngeal carcinoma: a promising new era	9
Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity	9
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort	9
Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany	9
CCL5 production by fibroblasts through a local renin–angiotensin system in malignant melanoma affects tumor immune responses	9
A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer	9
Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression	9